hydromorphone + butorphanol

Hydromorphone + butorphanol is a combination of two opioid analgesics used together for pain management, primarily in veterinary and perioperative settings. Hydromorphone is a synthetic full agonist of the μ-opioid receptor (mu), providing potent analgesia suitable for moderate to severe pain. Butorphanol acts as an agonist at the κ-opioid receptor (kappa) and as an antagonist or partial agonist at the μ-opioid receptor, offering milder analgesia with a shorter duration. When combined, butorphanol can reduce some adverse effects associated with pure mu-agonists like hydromorphone (such as dysphoria or excessive sedation), though it may also decrease the intensity of analgesia while extending its duration. This combination has been studied in both human and animal models for multimodal pain control, including post-surgical and procedural settings[1][2][6].